Therapy Market Research Reports
Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
... a challenge to the growth of this market. TechNavio's report, the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016, has been ... inputs from industry experts. The report covers the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market landscape and its growth ...
May, 2013 51 pages... options could pose a challenge to the growth of this market. TechNavio's report, the Global Melanoma Therapeutics market 2012-2016, has been prepared based on an ... Vical Inc. Key questions answered in this report: What will the market size be in 2016 and what will the growth rate be? What are the key ...
May, 2013 37 pagesEpiCast Report: Asthma - Epidemiology Forecast to 2022 Summary Asthma is one of the most common chronic diseases in the world, with an estimated 300 ... that there will be approximately 159.20 million lifetime prevalent cases of asthma in the 10 major markets by 2022, with an overall growth of 17.7% over the ...
May, 2013 79 pages... key players involved in the therapeutic development for Wrinkles. Wrinkles - Pipeline Review, Half Year is built using data and information sourced ... understand important and diverse types of therapeutics under development for Wrinkles. Identify emerging players with potentially strong product portfolio and ...
May, 2013 49 pagesWest Nile Virus Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'West Nile Virus Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for West Nile Virus Infections, ...
May, 2013 43 pages... key players involved in the therapeutic development for Tinnitus. Tinnitus - Pipeline Review, Half Year is built using data and information sourced ... understand important and diverse types of therapeutics under development for Tinnitus. Identify emerging players with potentially strong product portfolio and ...
May, 2013 45 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Staphylococcus Aureus Infections pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
May, 2013 394 pages... reviews key players involved in the therapeutic development for Spinal Stenosis. Spinal Stenosis - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 33 pages... reviews key players involved in the therapeutic development for Skin Infections. Skin Infections - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 56 pages... – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Review, H1 2013', provides ... based on the availability and relevance of data for the indicated disease. Scope A snapshot of the global therapeutic scenario for Skin And ...
May, 2013 88 pages... key players involved in the therapeutic development for Sjogren's Syndrome. Sjogren's Syndrome - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 35 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Shigella Infections (Shigellosis) pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
May, 2013 41 pagesSevere Acute Respiratory Syndrome (SARS) Coronavirus Infection – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides ...
May, 2013 50 pagesSecondary Progressive Multiple Sclerosis (SPMS) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic ...
May, 2013 58 pages... . This report provides information on the therapeutic development for Sarcoidosis, complete with latest updates, and special features on late-stage and ... key players involved in the therapeutic development for Sarcoidosis. Sarcoidosis - Pipeline Review, Half Year is built using data and information sourced ...
May, 2013 48 pages... key players involved in the therapeutic development for Rubella. Rubella - Pipeline Review, Half Year is built using data and information sourced ... and understand important and diverse types of therapeutics under development for Rubella. Identify emerging players with potentially strong product portfolio and ...
May, 2013 29 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Retinitis Pigmentosa (Retinitis) pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
May, 2013 49 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Respiratory Tract Infections pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating ...
May, 2013 147 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Respiratory Distress Syndrome pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
May, 2013 86 pages... reviews key players involved in the therapeutic development for Raynauds Disease. Raynauds Disease - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 42 pages... reviews key players involved in the therapeutic development for Ragweed Allergy. Ragweed Allergy - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 30 pages... key players involved in the therapeutic development for Pulmonary Fibrosis. Pulmonary Fibrosis - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 199 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Pseudomonas Aeruginosa Infections pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
May, 2013 132 pages... Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Premenstrual Syndrome. Premenstrual Syndrome - Pipeline Review, Half Year is built using data and information sourced ...
May, 2013 31 pages... reviews key players involved in the therapeutic development for Pain. Pain - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 404 pages... reviews key players involved in the therapeutic development for Ovarian Disease. Ovarian Disease - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 30 pages... for Obsessive-Compulsive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder. Obsessive-Compulsive Disorder - Pipeline Review, Half Year is built using data ...
May, 2013 53 pages... features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurofibromatoses. Neurofibromatoses - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University ...
May, 2013 41 pages... key players involved in the therapeutic development for Neuralgia. Neuralgia - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 473 pages... . This report provides information on the therapeutic development for Nephropathy, complete with latest updates, and special features on late-stage and ... key players involved in the therapeutic development for Nephropathy. Nephropathy - Pipeline Review, Half Year is built using data and information sourced ...
May, 2013 49 pages... reviews key players involved in the therapeutic development for Myasthenia Gravis. Myasthenia Gravis - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 59 pages... reviews key players involved in the therapeutic development for Mumps. Mumps - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 34 pagesMethicillin-Susceptible Staphylococcus Aureus (MSSA) Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides ...
May, 2013 46 pages... on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Low Back Pain pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and understand ...
May, 2013 74 pages... reviews key players involved in the therapeutic development for Liver Cirrhosis. Liver Cirrhosis - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 60 pages... Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Infectitious Diarrhea. Infectitious Diarrhea - Pipeline Review, Half Year is built using data and information sourced ...
May, 2013 35 pagesInclusion Body Myositis (IBM) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Inclusion Body Myositis (IBM) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Inclusion Body Myositis ( ...
May, 2013 31 pages... on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypoxic-Ischemic Encephalopathy. Hypoxic-Ischemic Encephalopathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
May, 2013 28 pages... . This report provides information on the therapeutic development for Hypoglycemia, complete with latest updates, and special features on late-stage and ... key players involved in the therapeutic development for Hypoglycemia. Hypoglycemia - Pipeline Review, Half Year is built using data and information sourced ...
May, 2013 36 pages... Hyperuricemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperuricemia. Hyperuricemia - Pipeline Review, Half Year is built using data and information sourced from Global ...
May, 2013 58 pagesHyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development ...
May, 2013 59 pages... key players involved in the therapeutic development for High-Grade Glioma. High-Grade Glioma - Pipeline Review, Half Year is built using data ... pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 42 pages... (HAE), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ... on the basis of monotherapy and combined therapeutics. Coverage of the Hereditary Angioedema (HAE) pipeline on the basis of route of administration and molecule type ...
May, 2013 69 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Hepatic (Liver) Metastasis pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating ...
May, 2013 46 pages... key players involved in the therapeutic development for Hemorrhage. Hemorrhage - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 38 pages... , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Heart Transplantation. Heart Transplantation - Pipeline Review, Half Year is built using data and information sourced from ...
May, 2013 37 pagesHaemophilus Influenzae Type b Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for ...
May, 2013 48 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Haemophilus Influenzae Infections pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
May, 2013 83 pages... . This report provides information on the therapeutic development for Grass Pollen Allergy, complete with latest updates, and special features on late ... on the basis of monotherapy and combined therapeutics. Coverage of the Grass Pollen Allergy pipeline on the basis of route of administration and molecule type ...
May, 2013 36 pagesGenital Warts (Condylomata Acuminata) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Genital ...
May, 2013 52 pages
